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Spontaneous fenestration closure is likely an indicator of
good Fontan physiology and a favorable clinical outcome.
Persistent fenestration at 6 to 12 months was a marker for
physiologic intolerance as noted by higher mortality and a
higher incidence of Fontan failure/complications. Late
fenestration patency was clearly important in 3% of the
total population. The specificity of pre-Fontan physiologic
data for fenestration status may not have the fidelity needed
for long-term care and thus, the consequences of decision
making regarding fenestration status may not be determined
until well after the operation.References
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1995;12:230-6.MMENTARYTo fenestrate or not: The Fontan debate gets more complicatedCharles D. Fraser, Jr, MDExpectations for acute postoperative outcomes after
Fontan’s palliation for single ventricle physiology have
increased dramatically during the past 2 decades. Many
centers report operative mortality rates of 1% or less
with progressively shorter hospital lengths of stay and
fewer perioperative complications. Patients are routinely
extubated either in the operating room or within the first
several postoperative hours and it is not uncommon for pa-
tients to stay in an intensive care unit for fewer than
24 hours. For those of us who grew up in the earlier era
of Fontan procedures, particularly in the era of atriopulmo-
nary connections, the differences in acute outcomes are




DThe most common method for completing a Fontan
pathway in the current era is through some form of total cav-
opulmonary connection (TCPC)—most frequently an
extracardiac TCPC. There remains significant surgeon and
interinstitution variability in specific surgical methodology.
Quite clearly, one of the most distinct differences in philos-
ophy is the decision to fenestrate all, fenestrate none, or
selectively fenestrate the Fontan channel. The physiologic
basis for the acute benefits of a fenestration in terms
of improving cardiac output (ventricular preload) and
lowering systemic venous pressure are generally accepted.
In our experience, the need for this physiologic adjunct
has largely been unnecessary because we have added
routine intraoperative extubation to our management proto-
col, where one typically sees an enormous improvement
in hemodynamic parameters immediately after transition-
ing from positive pressure ventilation to spontaneous
normal respiration. As such, we have largely abandoned
fenestration in our patients, yet we realize that our practice
may be quite different from that of other institutions. This
observation typifies the debate one might find in various ac-
ademic forums, and to date the literature has been conflicted
in terms of demonstrating superiority of one approach over
another.1-3
What we all do agree on is that the Fontan circulation is a
compromised circulation and that we continue to learn about
the long-term deleterious effects of this physiology. As such,
I find this month’s article by Kotani and colleagues4 highly
provocative and a reminder that we still have much to learn
about how to not only apply the Fontan operation, but also
how to assess patients on an ongoing basis. Briefly, in a
review of their almost 20-year experience with a consistent
approach to constructing the Fontan pathway, including an
extracardiac TCPC with routine fenestration, the authors
have observed a striking disadvantage in terms of complica-
tions andmortality in patients who have a persistent fenestra-
tion. As noted, the consistent management strategy in their
institution has been to routinely assess patients for Fontan
fenestration closure 1 year after the index operation. Despite
their large experience and the fact that they could not objec-
tively demonstrate a difference in preoperative variables
widely accepted to be predictive of Fontan outcomes, a sub-
group of their patients could not physiologically tolerate
ultimate fenestration closure, and these patients have much
poorer outcomes.
As I see it, there are several ways to interpret these data
and findings. One obvious concern is that even in the learned
hands of very experienced surgeons and cardiologists in a
preeminent center, there are patients who are beingThe Journal of Thoracic and Carpromoted to the Fontan operation who are not going to do
well, even at midterm follow-up (the median duration after
Fontan in the patent fenestration group in this series was
only 5 years). This is a very sobering observation and con-
firms my bias that we often see the Fontan operation as an
end, rather than 1 of many tools to achieve appropriate
long-term palliation. There are clearly patients who we put
forward for the Fontan procedure who are not really helped
in the long run. How can we improve on this problem?
Kotani and colleagues4 leave us with a rather incomplete
conclusion: ‘‘Given the unpredictable nature of fenestration
requirements, routine creation of a fenestration in standard-
risk patients still seems to be a reasonable strategy, recog-
nizing that many patients do not need fenestration at any
point..’’ What are we to do with this conclusion? I believe
the message is much more important and does not really
have anything to do with the decision to fenestrate. It seems
clear that the real issue is that we still have much room for
improvement in assessing patient candidacy for the Fontan
procedure and in securing a durable, long-term Fontan cir-
culation. As the authors correctly note, it is probable that
currently accepted Fontan criteria do not have the fidelity
to discern subtle interindividual variations that lead some
patients to experience a poor long-term outcome. Perhaps
Fontan criteria should be further refined to look at other de-
tails, including respiratory mechanics, functional reserve,
routine exercise physiology, and cardiac relaxation proper-
ties? Are we creating ‘‘ideal’’ Fontan pathways for all
patients or are there subtle technical, geometric, and func-
tional deficiencies that are not revealed early, but result
in a bad long-term result? Should all patients undergoing
the Fontan operation—irrespective of initial pulmonary
vascular resistance—be treated with chronic pulmonary
vasodilator therapies? Of course, these and other important
avenues of investigation will require thoughtful study, but
the challenge is there for us to embrace. Until then, we
will all be left with the conundrum, to fenestrate or not to
fenestrate?
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